Skip to main content
Clearside Biomedical, Inc. (CLSDQ)
OTCMKTS · Delayed Price · Currency is USD
0.790
-0.110 (-12.22%)
At close: Dec 5, 2025

Clearside Biomedical Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
 TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
 Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Net Income
-26-34.35-32.49-32.950.38-18.21
Upgrade
Depreciation & Amortization
0.330.230.070.150.180.18
Upgrade
Other Amortization
-----0.13
Upgrade
Loss (Gain) From Sale of Assets
---0.03--
Upgrade
Stock-Based Compensation
3.334.514.24.885.053.6
Upgrade
Other Operating Activities
2.976.599.363.28-10.06
Upgrade
Change in Accounts Payable
-2.34-1.430.610.690.68-0.63
Upgrade
Change in Unearned Revenue
--0.08-0.130.21-5-
Upgrade
Change in Other Net Operating Assets
0.42-0.170.2410.34-11.021.75
Upgrade
Operating Cash Flow
-21.29-24.7-18.14-13.37-10.73-13.12
Upgrade
Capital Expenditures
-0.45-0.98-1.78-0.25--0.06
Upgrade
Investment in Securities
9.750.34----
Upgrade
Investing Cash Flow
9.3-0.64-1.78-0.25--0.06
Upgrade
Long-Term Debt Issued
-----0.99
Upgrade
Long-Term Debt Repaid
------5.34
Upgrade
Net Debt Issued (Repaid)
------4.35
Upgrade
Issuance of Common Stock
3.5116.441.760.723.7812.22
Upgrade
Other Financing Activities
1.4--1.3530.64--
Upgrade
Financing Cash Flow
4.9116.440.4131.3323.787.87
Upgrade
Net Cash Flow
-7.09-8.9-19.517.7213.05-5.31
Upgrade
Free Cash Flow
-21.75-25.68-19.91-13.61-10.73-13.18
Upgrade
Free Cash Flow Margin
-653.23%-1542.97%-242.06%-1025.70%-36.29%-166.90%
Upgrade
Free Cash Flow Per Share
-4.22-5.22-4.83-3.39-2.69-4.25
Upgrade
Cash Interest Paid
-----0.52
Upgrade
Levered Free Cash Flow
-20.53-22.48-17.93-4.49-10.35-6.4
Upgrade
Unlevered Free Cash Flow
-13.91-16.37-12.08-2.4-10.35-6.32
Upgrade
Change in Working Capital
-1.92-1.680.7211.24-15.341.12
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.